First CRISPR-Based Therapies For Sickle Cell Disease and Beta Thalassemia Approved In The UK
The gene-therapy-based treatment called Casgevy was recently approved in the UK, making it the first time that a treatment based on the CRISPR-Cas9 gene editing tool has been authorized for …read more Continue reading First CRISPR-Based Therapies For Sickle Cell Disease and Beta Thalassemia Approved In The UK
